Pascal Touchon, President and CEO at Atara Biotherapeutics, Inc. (ATRA), sold 14,220 shares at $7.20 ($102K) on 2022-06-27, disclosed to the SEC on 2022-06-29.
Seasonal sale ($102k) by President and CEO — this insider has traded ATRA in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ATRA | SELL | 2024-03-06 | $18K | — | Filing → |
| ATRA | SELL | 2023-11-20 | $8K | — | Filing → |
| ATRA | SELL | 2023-08-18 | $51K | — | Filing → |